I agree that this site is using cookies. You can find further informations here.
X
Kosoglou, Teddy
35  results:
Search for persons X
?
1

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination ..:

O'Neil, Brian ; Ison, Michael G ; Hallouin-Bernard, Marie Charlotte...
The Journal of Infectious Diseases.  226 (2020)  1 - p. 109-118 , 2020
Link: https://doi.org/10.1093/..
 
?
2

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy o..:

Finberg, Robert W ; Lanno, Riin ; Anderson, David...
The Journal of Infectious Diseases.  219 (2018)  7 - p. 1026-1034 , 2018
Link: https://doi.org/10.1093/..
 
?
3

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel ..:

Anderson, Matt S. ; Kosoglou, Teddy ; Statkevich, Paul...
Clinical Pharmacology in Drug Development.  7 (2017)  2 - p. 143-150 , 2017
Link: https://doi.org/10.1002/..
 
?
4

Evaluation of potential for pharmacokinetic interaction bet..:

Kosoglou, Teddy ; Hubbell, James ; Johnson‐Levonas, Amy O....
Clinical Pharmacology in Drug Development.  3 (2014)  3 - p. 222-228 , 2014
Link: https://doi.org/10.1002/..
 
?
5

An evaluation of the systemic bioavailability of mometasone..:

Kosoglou, Teddy ; Hubbell, James ; Kantesaria, Bhavna..
Clinical Pharmacology in Drug Development.  3 (2014)  3 - p. 229-234 , 2014
Link: https://doi.org/10.1002/..
 
?
6

Vorapaxar, an oral PAR‐1 receptor antagonist, does not affe..:

Kosoglou, Teddy ; Kumar, Bharath ; Statkevich, Paul...
Clinical Pharmacology in Drug Development.  4 (2014)  1 - p. 56-62 , 2014
Link: https://doi.org/10.1002/..
 
?
7

Pharmacokinetics of vorapaxar and its metabolite following ..:

Chen, Xia ; Kosoglou, Teddy ; Statkevich, Paul...
Int. Journal of Clinical Pharmacology and Therapeutics.  52 (2014)  10 - p. 889-899 , 2014
Link: https://doi.org/10.5414/..
 
?
8

The Influence of Multiple‐Dose Vorapaxar, an Oral PAR‐1 Rec..:

Kosoglou, Teddy ; Zhu, Yali ; Statkevich, Paul...
Clinical Pharmacology in Drug Development.  2 (2013)  1 - p. 90-98 , 2013
Link: https://doi.org/10.1002/..
 
?
9

The Effect of Multiple Doses of Ketoconazole or Rifampin on..:

Kosoglou, Teddy ; Statkevich, Paul ; Kumar, Bharath...
The Journal of Clinical Pharmacology.  53 (2013)  5 - p. 540-549 , 2013
Link: https://doi.org/10.1002/..
 
?
10

Effect of Food, Antacid, and Age on the Pharmacokinetics of..:

Kosoglou, Teddy ; Reyderman, Larisa ; Tseng, Jack...
Clinical Pharmacology in Drug Development.  2 (2013)  3 - p. 223-230 , 2013
Link: https://doi.org/10.1002/..
 
?
11

Comparison of the systemic bioavailability of mometasone fu..:

Kosoglou, Teddy ; Hubbell ; Xuan...
International Journal of Chronic Obstructive Pulmonary Disease.  , 2013
Link: https://doi.org/10.2147/..
 
?
12

Effect of the thrombin receptor antagonist (PAR‐1) vorapaxa..:

Kosoglou, Teddy ; Hunt, Thomas L. ; Xuan, Fengjuan...
Clinical Pharmacology in Drug Development.  3 (2013)  1 - p. 18-24 , 2013
Link: https://doi.org/10.1002/..
 
?
13

The Absence of a Clinically Significant Effect of Food on t..:

Behm, Martin O. ; Kosoglou, Teddy ; Miltenburg, André M.M....
Clinical Pharmacology in Drug Development.  2 (2013)  4 - p. 310-315 , 2013
Link: https://doi.org/10.1002/..
 
?
14

Pharmacokinetics and pharmacodynamics of the novel PAR-1 an..:

Kosoglou, Teddy ; Kraft, Walter K. ; Kumar, Bharath...
European Journal of Clinical Pharmacology.  68 (2012)  7 - p. 1049-1056 , 2012
Link: https://doi.org/10.1007/..
 
?
15

Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in..:

Statkevich, Paul ; Kosoglou, Teddy ; Preston, Richard A....
European Journal of Clinical Pharmacology.  68 (2012)  11 - p. 1501-1508 , 2012
Link: https://doi.org/10.1007/..
 
1-15